146 related articles for article (PubMed ID: 31732173)
1. In reply to the letter to the editor regarding "Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study".
Zenesini C; Baldin E; Vignatelli L; D'Alessandro R
J Neurol Sci; 2020 Jan; 408():116511. PubMed ID: 31732173
[No Abstract] [Full Text] [Related]
2. Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study.
Zenesini C; Baldin E; Vignatelli L; Poluzzi E; Antonazzo I; Calandra-Buonaura G; Guarino M; De Carolis P; Cortelli P; D'Alessandro R;
J Neurol Sci; 2019 Oct; 405():116421. PubMed ID: 31422283
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants and Parkinson's disease: a causal association.
Kawada T
J Neurol Sci; 2020 Jan; 408():116512. PubMed ID: 31653396
[No Abstract] [Full Text] [Related]
4. Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
Weimers P; Halfvarson J; Saunders-Pullman R; Ludvigsson JF; Peter I; Olén O; Burisch J
Inflamm Bowel Dis; 2019 Sep; 25(10):e127. PubMed ID: 31406980
[No Abstract] [Full Text] [Related]
5. Reply to letter to the editor "Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges".
Velisar A; Bronte-Stewart H
Brain Stimul; 2019; 12(5):1330-1331. PubMed ID: 31235368
[No Abstract] [Full Text] [Related]
6. Recognition and treatment of depressive symptoms in Parkinson's disease: the NPF dataset.
Bega D; Wu SS; Pei Q; Schmidt PN; Simuni T
J Parkinsons Dis; 2014; 4(4):639-43. PubMed ID: 25035310
[TBL] [Abstract][Full Text] [Related]
7. Reply to the Letter to the Editor "The Microbiota in Parkinson's Disease: Ranking the Risk of Heart Disease".
Hirayama M; Ohno K
Ann Nutr Metab; 2022; 78(2):119-120. PubMed ID: 35042218
[No Abstract] [Full Text] [Related]
8. Use of antidepressants for depression in patients with Parkinson's disease.
Pae CU
Expert Opin Pharmacother; 2013 Feb; 14(3):255-7. PubMed ID: 23316679
[No Abstract] [Full Text] [Related]
9. Use of antidepressants in Parkinson's disease: A Swedish register-based study of over 1.5 million older people.
Haasum Y; Fastbom J; Johnell K
Parkinsonism Relat Disord; 2016 Jun; 27():85-8. PubMed ID: 27117031
[TBL] [Abstract][Full Text] [Related]
10. Reply to: 'Letter to the Editor on "Sex Differences in Parkinson's Disease Phenotype and Caregiving Disparities"'.
Antar T; Iwaki H; B Singleton A
Mov Disord; 2021 Feb; 36(2):527-528. PubMed ID: 33599005
[No Abstract] [Full Text] [Related]
11. Reply to letter to the editor "tDCS effect on cognitive performance in Parkinson's disease" by Biundo et al.
Cotelli M; Manenti R; Brambilla M; Borroni B
Mov Disord; 2016 Aug; 31(8):1253-5. PubMed ID: 27270985
[No Abstract] [Full Text] [Related]
12. The effects of antidepressants in Parkinson's disease: a meta-analysis.
Frisina PG; Tenenbaum HR; Borod JC; Foldi NS
Int J Neurosci; 2008 May; 118(5):667-82. PubMed ID: 18446583
[TBL] [Abstract][Full Text] [Related]
13. In reply to the letter to the editor regarding "TGM6 variants in Parkinson's disease: clinical findings and functional evidence".
Chen K; Tan Y; Zhao YX
J Integr Neurosci; 2020 Dec; 19(4):739-740. PubMed ID: 33378850
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic markers for Parkinson's disease.
Chahine LM; Stern MB
Curr Opin Neurol; 2011 Aug; 24(4):309-17. PubMed ID: 21464716
[TBL] [Abstract][Full Text] [Related]
16. Therapies for depression in Parkinson's disease.
Shabnam GN; Th C; Kho D; H R; Ce C
Cochrane Database Syst Rev; 2003; (3):CD003465. PubMed ID: 12917968
[TBL] [Abstract][Full Text] [Related]
17. Intervening in the neuropsychiatric features of Parkinson's disease.
Weintraub D; Stern MB
Expert Rev Neurother; 2007 Jun; 7(6):699-710. PubMed ID: 17563252
[TBL] [Abstract][Full Text] [Related]
18. Association between antidepressants and falls in Parkinson's disease.
Martinez-Ramirez D; Giugni JC; Almeida L; Walz R; Ahmed B; Chai FA; Rundle-Gonzalez V; Bona AR; Monari E; Wagle Shukla A; Hess CW; Hass CJ; Okun MS
J Neurol; 2016 Jan; 263(1):76-82. PubMed ID: 26514836
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for depression and psychosis in Parkinson's disease.
Poewe W; Seppi K
J Neurol; 2001 Sep; 248 Suppl 3():III12-21. PubMed ID: 11697683
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced parkinsonism as a risk factor for Parkinson's disease: a historical cohort study in Olmsted County, Minnesota.
Chabolla DR; Maraganore DM; Ahlskog JE; O'Brien PC; Rocca WA
Mayo Clin Proc; 1998 Aug; 73(8):724-7. PubMed ID: 9703296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
